Market Tracker

04/17 6:02pm ET

Exelixis Inc (NASDAQ:EXEL)

3.11
Delayed Data
As of Apr 17
 +0.01 / +0.32%
Today’s Change
1.26
Today|||52-Week Range
4.55
+115.97%
Year-to-Date

Today’s Trading

Previous close3.10
Today’s open3.10
Day’s range3.03 - 3.14
Volume1,719,650
Average volume (3 months)3,900,477
Market cap$609.3M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-3.76%
Earnings growth (this year)+37.32%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-19.87%
P/E ratioNM
Price/Sales11.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...-0.31-1.62%
LXRXLexicon Pharmaceutic...+0.04+4.05%
FLXNFlexion Therapeutics...-1.71-8.17%
AMRNAmarin Corporation P...-0.04-1.69%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 1, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$25.1M
Annual profit (last year)-$268.5M
Net profit margin-1,069.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts